Skip to main content
. 2021 May 12;3(9):1117–1124. doi: 10.1016/j.cjco.2021.05.001

Table 1.

Baseline patient characteristics over the study period, 2008 to 2018

Year 2008(n = 148) 2010(n = 267) 2012(n = 310) 2014(n = 584) 2016(n = 753) 2018(n = 373) Modeled linear regression P value*
Age, y 63 ± 13 62 ± 13 62 ± 13 63 ± 13 62 ± 14 62 ± 13 0.60
Female 41 (32) 73 (27) 102 (33) 180 (31) 218 (29) 108 (29) 0.46
Hypertension 80 (63) 188 (70) 222 (72) 422 (72) 506 (67) 254 (68) 0.86
Connective tissue disorder 0.23
 None 117 (94) 235 (89) 279 (91) 539 (93) 723 (96) 350 (94)
 Confirmed 8 (6.4) 28 (11) 27 (8.8) 42 (7.2) 28 (3.7) 22 (5.9)
 Suspected 0 (0) 0 (0) 2 (0.65) 1 (0.17) 1 (0.13) 0 (0)
Diabetes mellitus 12 (9.4) 35 (13) 38 (12) 63 (11) 95 (13) 45 (12) 0.67
Dyslipidemia 45 (36) 136 (52) 149 (49) 270 (46) 324 (43) 134 (36) 0.29
Renal failure 16 (13) 28 (10) 28 (9) 54 (9.2) 44 (5.8) 20 (5.4) < 0.01
Cerebrovascular disease 18 (12) 23 (8.6) 34 (11) 61 (10) 67 (8.9) 41 (11) 0.48
Peripheral vascular disease 20 (14) 53 (20) 56 (18) 84 (14) 79 (10) 32 (8.6) 0.77
Smoker 63 (43) 140 (52) 140 (45) 253 (43) 304 (40) 139 (37) < 0.001
COPD 25 (20) 45 (17) 40 (13) 77 (13) 70 (9.3) 43 (12) < 0.001
Previous cardiac surgery 20 (16) 47 (18) 47 (15) 112 (19) 117 (16) 51 (14) 0.61
Atrial fibrillation 20 (16) 31 (12) 44 (14) 74 (13) 89 (12) 35 (9.4) 0.26
Coronary artery disease 19 (15) 59 (22) 64 (21) 144 (25) 143 (19) 63 (17) 0.37
LVEF, % 0.48
 > 60 97 (76) 197 (74) 257 (83) 469 (80) 571 (76) 293 (79)
 40–60 23 (18) 54 (20) 30 (10) 81 (14) 125 (17) 58 (16)
 20–40 6 (4.7) 14 (5.2) 19 (6.1) 22 (3.8) 49 (6.5) 16 (4.3)
 < 20 2 (1.6) 2 (0.75) 4 (1.3) 12 (2.1) 8 (1.1) 6 (1.6)
Anatomy
 Body surface area, m2 1.9 ± 0.2 1.9 ± 0.2 2.0 ± 0.2 1.9 ± 0.2 2.0 ± 0.3 2.0 ± 0.3 < 0.001
 Maximum aortic diameter, mm 58 ± 13 55 ± 11 54 ± 12 53 ± 10 52 ± 12 53 ± 11 < 0.01
 Maximum indexed aortic
diameter, mm/m2
31 ± 8 29 ± 7 28 ± 7 28 ± 12 27 ± 7 27 ± 6 < 0.001
Aortic valve anatomy 0.42
 Tricuspid valve 97 (76) 196 (74) 208 (68) 386 (68) 520 (73) 268 (72)
 Bicuspid valve 31 (24) 68 (26) 95 (31) 174 (31) 193 (27) 97 (26)
 Unicuspid valve 0 (0) 0 (0) 2 (0.66) 5 (0.88) 3 (0.42) 5 (1.4)
Aortic stenosis 24 (19) 59 (22) 80 (26) 160 (27) 218 (29) 125 (34) < 0.001
Aortic insufficiency 62 (48) 144 (54) 166 (54) 312 (53) 359 (48) 198 (53) 0.02
Presentation
 Acute dissection or rupture 38 (30) 69 (26) 65 (21) 135 (23) 181 (24) 81 (22) 0.03
 Dissection 51 (40) 110 (41) 108 (35) 198 (34) 243 (32) 112 (30) 0.01
 Rupture 8 (6.3) 16 (6.0) 16 (5.2) 31 (5.3) 37 (4.9) 15 (4.0) 0.17
Urgency status 0.04
 Elective 64 (50) 146 (55) 202 (65) 384 (66) 477 (63) 249 (67)
 Urgent 25 (20) 44 (16) 38 (12) 58 (10) 80 (11) 34 (9.1)
 Emergent (< 6 h) 36 (28) 70 (26) 61 (20) 133 (23) 186 (25) 81 (22)
 Salvage 3 (2.3) 7 (2.6) 9 (2.9) 9 (1.5) 10 (1.3) 9 (2.4)
 Emergent or salvage 39 (30) 77 (29) 70 (23) 142 (24) 196 (26) 90 (24) 0.04

Table shows trends in baseline characteristics in 2435 patients who underwent aortic arch surgery with hypothermic circulatory arrest, between 2008 and 2018, in 12 institutions across Canada. Values are n (%) or mean ± standard deviation.

COPD, chronic obstructive pulmonary disease; LVEF, left ventricular ejection fraction.

Whether these characteristics changed significantly over time was assessed by mixed-effect linear regression models using date of surgery as a continuous variable to assess a linear trend across the years from 2008 to 2018.